2026 is highlighted as the year of the singularity with Elon Musk warning of underestimated impacts; conversations with him ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

AI coding agents from OpenAI, Anthropic, and Google can now work on software projects for hours at a time, writing complete apps, running tests, and fixing bugs with human supervision. But these tools ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Henry Chandonnet Every time Henry publishes a story, you’ll get an alert straight to your inbox ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion Pharmaceuticals announced positive Phase 1b/2 results from its ongoing TUPELO trial ...

I Finally Tried Vibe Coding and the Results Were Miraculous I have zero programming skills. But after a few minor setbacks, I was able to build a custom website in no time.

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...